Create Account
Log In
Dark
chart
exchange
Premium
Terminal
Screener
Stocks
Crypto
Forex
Trends
Depth
Close
Check out our Dark Pool Levels


Precision BioSciences Receives Fast Track Designation From FDA For PBCAR269A Investigational Allogeneic CAR T Therapy For Relapsed/Refractory Multiple Myeloma


Benzinga | Sep 9, 2020 07:27AM EDT

Precision BioSciences Receives Fast Track Designation From FDA For PBCAR269A Investigational Allogeneic CAR T Therapy For Relapsed/Refractory Multiple Myeloma






Share
About
Pricing
Policies
Markets
API
Info
tz UTC-4
Connect with us
ChartExchange Email
ChartExchange on Discord
ChartExchange on X
ChartExchange on Reddit
ChartExchange on GitHub
ChartExchange on YouTube
© 2020 - 2026 ChartExchange LLC